The biotech IPO window looks like it’s reopening. This past week closed with three biotech companies joining the public markets, a flurry of activity that helped make April the biggest
From how deals get sourced to how capital allocators think, generative AI is reshaping how venture capital works. For many, it’s seen as a positive, and there are truly great
What do diabetes, obesity, chronic kidney disease, liver disease, cardiovascular disease, and even some cancer have in common? They are all metabolic conditions – sometimes caused, or worsened by poor
For years, healthcare treated AI as a series of separate bets. We had one tool for documentation, another for remote monitoring, and a handful for imaging. This fragmented approach mirrored
Here is the central absurdity of clinical Digital Out-of-Home (DOOH): screen owners have constructed the most intentful advertising environment in healthcare — a captive, health-focused audience, sitting with a specific
A new social media platform exclusively for doctors launched this week. The free platform, called Roon, was founded by Vikram Bhaskaran and Arun Ranganathan, two former Pinterest leaders who serve
Agitation is a common Alzheimer’s disease symptom, manifesting as pacing and restlessness as well as verbal and physical aggression to family members and caregivers. The drugs used to quell these
The few drugs available for lung disorders that cause scarring of the organ are pills that circulate throughout the body. Avalyn Pharma is aiming for a better effect with inhalable
Pharmacy benefit manager reform is not isolated to Congressional action. Even states such as Tennessee are wading in. Last year, Arkansas became the first state to sign a law that
Welcome back to another episode of MedCity FemFwd, a podcast dedicated to exploring the breakthroughs and challenges in women’s health. In this episode, we’re joined by Meghan Doyle, CEO of
